Wax Drug Company, Inc. is hoping that 2018 will be a great year for Alzheimer’s drugs.
The company is the first drug company to be granted approval for Alzheimers drug-delivery vehicle (DV) services.
The startup’s vehicle will carry its Alzheimer’s drug and its driver will be able to travel to any location in the world.
The company, based in Fort Worth, Texas, is currently in negotiations with the U.S. Food and Drug Administration (FDA) to provide a driver for the company’s Alzheimer’s vehicle, which will be equipped with its patented technology to make sure the driver is on the road for as long as possible.
Wax is also planning to launch a driverless car in 2019.
The startup has been awarded an “emergency vehicle” designation by the FDA and will soon have a vehicle in operation at a test site in Fort Lauderdale, Florida.
Wax will be responsible for the driver, which is equipped with a camera and GPS.
According to the FDA’s latest guidelines, drivers must be at least 21 years old and be certified in a test.
A medical certificate is also required.
The driver will have to drive for at least four consecutive hours and complete a daily safety evaluation.
The driver will also have to provide wax samples to the company and its testing laboratory.
Wax hopes to have the vehicle in service in 2018.
The FDA says the company is confident in its process, and says it plans to continue developing and testing its drug-dumping vehicle technology.
The vehicle is expected to begin shipping in 2019, and Wax expects to be able have the first vehicle in the market by 2021.